D Pulanic E W Cowen K Baird M R Bishop S Z Pavletic
10.1038/bmt.2009.368
Bone Marrow Transplant
2010 Sep;45(9):1469-70.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/20062096/
Graft vs Host Disease / etiology Hematopoietic Stem Cell Transplantation / adverse effects Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Protein Kinase Inhibitors / adverse effects Pyrimidines / adverse effects Thiazoles / adverse effects
Graft vs Host Disease / etiology Hematopoietic Stem Cell Transplantation / adverse effects Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Protein Kinase Inhibitors / adverse effects Pyrimidines / adverse effects Thiazoles / adverse effects Case Reports Letter Research Support, N.I.H., Intramural Chronic Disease Combined Modality Therapy Dasatinib Graft vs Host Disease / pathology Humans Male Sclerosis Severity of Illness Index Young Adult Protein Kinase Inhibitors Pyrimidines Thiazoles Dasatinib
PMC7365192
20062096
Development of severe sclerotic chronic GVHD during treatment with dasatinib
2010